These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19203099)

  • 1. Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.
    Gregori S; Battaglia M; Roncarolo MG
    Novartis Found Symp; 2008; 292():174-83; discussion 183-6, 202-3. PubMed ID: 19203099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of New Onset Type 1 Diabetes by Oral
    Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI
    Front Immunol; 2019; 10():320. PubMed ID: 30863412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models.
    Yin B; Ma G; Yen CY; Zhou Z; Wang GX; Divino CM; Casares S; Chen SH; Yang WC; Pan PY
    J Immunol; 2010 Nov; 185(10):5828-34. PubMed ID: 20956337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma.
    McGee HS; Agrawal DK
    Immunol Res; 2006; 35(3):219-32. PubMed ID: 17172648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
    Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
    Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin B chain 9-23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs.
    Akbarpour M; Goudy KS; Cantore A; Russo F; Sanvito F; Naldini L; Annoni A; Roncarolo MG
    Sci Transl Med; 2015 May; 7(289):289ra81. PubMed ID: 26019217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
    Jaeckel E; Mpofu N; Saal N; Manns MP
    Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low CD25 on autoreactive Tregs impairs tolerance via low dose IL-2 and antigen delivery.
    Hotta-Iwamura C; Benck C; Coley WD; Liu Y; Zhao Y; Quiel JA; Tarbell KV
    J Autoimmun; 2018 Jun; 90():39-48. PubMed ID: 29439835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
    Siepmann K; Biester S; Plsková J; Muckersie E; Duncan L; Forrester JV
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):221-9. PubMed ID: 16741709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.
    Jaberi-Douraki M; Pietropaolo M; Khadra A
    J Theor Biol; 2015 Oct; 383():93-105. PubMed ID: 26271890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An altered CD8
    Zhang M; Wang S; Guo B; Meng G; Shu C; Mai W; Zheng Q; Chen X; Wu Y; Wang L
    Cell Mol Immunol; 2019 Jun; 16(6):590-601. PubMed ID: 29955175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes.
    Li CR; Baaten BJ; Bradley LM
    J Mol Cell Biol; 2012 Feb; 4(1):38-47. PubMed ID: 22116888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4(+) CD25(+) T regulatory cells do not transfer oral tolerance to peanut allergens in a mouse model of peanut allergy.
    Marcondes Rezende M; Hassing I; Bol-Schoenmakers M; Bleumink R; Boon L; van Bilsen J; Pieters R
    Clin Exp Allergy; 2011 Sep; 41(9):1324-33. PubMed ID: 21338425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms.
    Yuan X; Dong Y; Tsurushita N; Tso JY; Fu W
    JCI Insight; 2018 Jan; 3(2):. PubMed ID: 29367461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
    Brode S; Raine T; Zaccone P; Cooke A
    J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
    Sgouroudis E; Albanese A; Piccirillo CA
    J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.